Minami H, Sai K, Saeki M, et al.: Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1* 6 and* 28. Pharmacogenet Genomics.17: 497-504.2007.
Gagné JF, Montminy V, Belanger P, et al.: Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol.62: 608-617.2002.